Anti-p27 KIP 1 antibody [EPFHCR16]
- 20ul selling size
- RabMAb
- Recombinant
- KO Validated
- What is this?
1
(1 Review)
|
(18 Publications)
Rabbit Recombinant Monoclonal p27 KIP 1 antibody. Suitable for IHC-P, WB and reacts with Mouse, Rat samples. Cited in 18 publications.
View Alternative Names
Cyclin-dependent kinase inhibitor 1B, Cyclin-dependent kinase inhibitor p27, p27Kip1, Cdkn1b
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-p27 KIP 1 antibody [EPFHCR16] (AB92741)
ab92741 at 1/100 dilution staining p27 KIP in Mouse thymus by Immunohistochemistry Paraffin-embedded tissue.
Heat mediated antigen retrieval was performed before commencing with IHC staining protocol.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-p27 KIP 1 antibody [EPFHCR16] (AB92741)
ab92741 at 1/100 dilution staining p27 KIP in Mouse lung by Immunohistochemistry Paraffin-embedded tissue.
Heat mediated antigen retrieval was performed before commencing with IHC staining protocol.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-p27 KIP 1 antibody [EPFHCR16] (AB92741)
Immunohistochemical analysis of paraffin-embedded rat testis tissue labeling p27 KIP 1 with ab92741 at 1/5000 dilution followed by Rabbit specific IHC polymer detection kit HRP/DAB (ab209101). Nuclear staining in Leydig and Sertoli cells and Leydig cells of rat testis is observed (PMID : 10098522). Counter stained with Hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody.
Heat mediated antigen retrieval was performed using Universal HIER antigen retrieval reagent (10X) (ab208572).
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-p27 KIP 1 antibody [EPFHCR16] (AB92741)
Immunohistochemical analysis of paraffin-embedded mouse testis tissue labeling p27 KIP 1 with ab92741 at 1/5000 dilution followed by Rabbit specific IHC polymer detection kit HRP/DAB (ab209101). Nuclear staining in Leydig and Sertoli cells and Leydig cells of mouse testis is observed (PMID : 10098522). Counter stained with Hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody.
Heat mediated antigen retrieval was performed using Universal HIER antigen retrieval reagent (10X) (ab208572).
- WB
Unknown
Western blot - Anti-p27 KIP 1 antibody [EPFHCR16] (AB92741)
All lanes:
Western blot - Anti-p27 KIP 1 antibody [EPFHCR16] (ab92741) at 1/1000 dilution
Lane 1:
NIH/3T3 cell lysate at 10 µg
Lane 2:
C6 cell lysate at 10 µg
Lane 3:
Neuro-2a cell lysate at 10 µg
Secondary
All lanes:
Goat anti-rabbit HRP-conjugated at 1/2000 dilution
Predicted band size: 22 kDa
Observed band size: 27 kDa
false
- WB
Lab
Western blot - Anti-p27 KIP 1 antibody [EPFHCR16] (AB92741)
False colour image of Western blot : Anti-p27 KIP 1 antibody [EPFHCR16] staining at 1/1000 dilution, shown in green; Mouse anti-Alpha Tubulin [DM1A] (ab7291) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab92741 was shown to bind specifically to p27 KIP 1. A band was observed at 28 kDa in wild-type RAW 264.7 cell lysates with no signal observed at this size in CDKN1B knockout cell line ab281619 (knockout cell lysate ab282970). To generate this image, wild-type and CDKN1B knockout RAW 264.7 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) at 1/20000 dilution.
All lanes:
Western blot - Anti-p27 KIP 1 antibody [EPFHCR16] (ab92741) at 1/1000 dilution
Lane 1:
Wild-type RAW 264.7 cell lysate at 20 µg
Lane 2:
CDKN1B knockout RAW 264.7 cell lysate at 20 µg
Lane 2:
Western blot - Mouse CDKN1B (p27 KIP 1) knockout RAW 264.7 cell line (<a href='/en-us/products/cell-lines/mouse-cdkn1b-p27-kip-1-knockout-raw-2647-cell-line-ab281619'>ab281619</a>)
Predicted band size: 22 kDa
Observed band size: 28 kDa
false
Related conjugates and formulations (1)
-
Anti-p27 KIP 1 antibody [EPFHCR16] - BSA and Azide free
Reactivity data
Product details
Species reactivity
Human: We have preliminary internal testing data to indicate this antibody may not react with this species.
Please contact us for more information.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The function of p27 KIP1 involves its role in controlling cell growth and division. It achieves this by becoming a part of larger protein complexes involving CDKs and cyclins. By directly interacting with these complexes p27 KIP1 modulates cell cycle progression therefore acting as a brake on cellular proliferation. The protein is important in maintaining proper cell cycle checkpoints and preventing uncontrolled cell growth which is essential for normal cellular functioning.
Pathways
The involvement of p27 KIP1 centers on cell cycle regulation and signaling pathways such as the PI3K/AKT pathway. Its interaction with CDKs and cyclins situates it within the core mechanisms that determine cell division timing. p27 KIP1 operates alongside other proteins like cyclin D and CDK4/6 fitting into the regulatory intricacies of these pathways. Proper functioning of these pathways ensures cellular homeostasis and prevents the development of oncogenic processes.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (18)
Recent publications for all applications. Explore the full list and refine your search
Communications biology 8:278 PubMed39987265
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cell communication and signaling : CCS 22:357 PubMed38987851
2024
Applications
Unspecified application
Species
Unspecified reactive species
Endocrine connections 11: PubMed35294398
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in cell and developmental biology 9:638815 PubMed33796530
2021
Applications
Unspecified application
Species
Unspecified reactive species
International journal of clinical and experimental 12:4066-4076 PubMed31933802
2019
Applications
Unspecified application
Species
Unspecified reactive species
Biomaterials 225:119539 PubMed31622821
2019
Applications
Unspecified application
Species
Unspecified reactive species
Journal of experimental & clinical cancer research 38:296 PubMed31288861
2019
Applications
Unspecified application
Species
Unspecified reactive species
Molecular medicine reports 20:2091-2100 PubMed31322237
2019
Applications
Unspecified application
Species
Unspecified reactive species
Diabetes 67:2615-2625 PubMed30257979
2018
Applications
Unspecified application
Species
Unspecified reactive species
Molecular biology of the cell 29:2922-2932 PubMed30256721
2018
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com